Monopar Therapeutics Inc (MNPR) Directors and Executive Officers

Officers & Directors

Christopher M. Starr -

Kim R. Tsuchimoto -

Michael J. Brown -

Arthur J. Klausner -

Chandler D. Robinson -

Raymond W. Anderson -

BPM LLP - We have served as Monopar Therapeutics Inc.,

Monopar Therapeutics Inc currently has 22 employees.

News about Monopar Therapeutics Inc Key Personnel

Monopar Therapeutics: Charting the Course Between Innovation and Financial Struggles

In a time when the biotechnology sector is brimming with promise and potential, Monopar Therapeutics Inc. (Nasdaq: MNPR) stands out as a beacon of hope—and, paradoxically, concern. The clinical-stage company, dedicated to developing groundbreaking treatments for unmet medical needs, recently secured funding through a public offering and private placement while simultaneously grappling with significant financial losses. Announcement of a $40 Million OfferingOn December 20, 2024, Monopar Therapeutics announced the pricing of an underwritten registered offering of 798,655 shares at $23.79 per share, alongside a concurrent private placement of pre-funded warrants. Collectively, these transactions are poised to...